Bausch Health Companies Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2016-08-23: Form 8-K; Exhibit 10.1; Description Amendment No. 13 to Third Amended and Restated Credit and Guaranty Agreement, dated as of August 23, 2016, by and among Valeant Pharmaceuticals International, Inc., the guarantors party thereto and Barclays Bank PLC, as administrative agent and on behalf of the requisite lenders and as Amendment No. 13 arranger..
- 2016-08-23: Form 8-K; Exhibit 10.1; Description Employment Agreement, dated as of August 17, 2016, between Valeant Pharmaceuticals International, Inc. and Paul S. Herendeen.
- 2016-05-31: Form 8-K; Exhibit 10.1; Description EXHIBIT 10.1 - SEPARATION AGREEMENT.
- 2016-05-16: Form 8-K; Exhibit 10.1; Description EXHIBIT 10.1 - FORM OF EXECUTIVE RETENTION LETTER AGREEMENT.
| Filed | Form | Exhibit | Description |
|---|
| 2016-08-23 | 8-K | 10.1 | Amendment No. 13 to Third Amended and Restated Credit and Guaranty Agreement, dated as of August 23, 2016, by and among Valeant Pharmaceuticals International, Inc., the guarantors party thereto and Barclays Bank PLC, as administrative agent and on behalf of the requisite lenders and as Amendment No. 13 arranger. |
|---|
| 2016-08-23 | 8-K | 10.1 | Employment Agreement, dated as of August 17, 2016, between Valeant Pharmaceuticals International, Inc. and Paul S. Herendeen |
|---|
| 2016-05-31 | 8-K | 10.1 | EXHIBIT 10.1 - SEPARATION AGREEMENT |
|---|
| 2016-05-16 | 8-K | 10.1 | EXHIBIT 10.1 - FORM OF EXECUTIVE RETENTION LETTER AGREEMENT |
|---|
| 2016-04-29 | 10-K | 10.28 | Employment Letter between Valeant Pharmaceuticals International, Inc. and Deborah Jorn, dated as of July 19, 2013. |
|---|
| 2016-04-29 | 10-K | 10.27 | Employment Letter between Valeant Pharmaceuticals International, Inc. and Anne Whitaker, dated as of April 25, 2015. |
|---|
| 2016-04-29 | 10-K | 10.26 | Employment Letter between Valeant Pharmaceuticals International, Inc. and Brian Stolz, dated as of July 1, 2015. |
|---|
| 2016-04-29 | 10-K | 10.5 | Form of Matching Restricted Stock Unit Award Agreement (Matching Units - EMT), under the 2014 Omnibus Incentive Plan. |
|---|
| 2016-04-27 | 8-K | 10.1 | EXHIBIT 10.1 - EMPLOYMENT AGREEMENT |
|---|
| 2016-04-11 | 8-K | 10.1 | Amendment No. 12 and Waiver to Third Amended and Restated Credit and Guaranty Agreement, dated as of April 11, 2016, by and among Valeant Pharmaceuticals International, Inc., the guarantors party thereto and Barclays Bank PLC, as administrative agent and on behalf of the requisite lenders and as Amendment No. 12 arranger. |
|---|
| 2016-02-02 | 8-K | 10.1 | Employment Letter between Howard B. Schiller and Valeant Pharmaceuticals International, Inc., dated February 1, 2016 |
|---|